Purchase Order 36C26124P0004
- Not listed
- The Department of Veterans Affairs, through Veterans Integrated Service Network 8, awarded a firm fixed-price purchase order to Sirtex Medical Inc. on October 1, 2024, for ten SIR-Spheres Y-90 resin microspheres with a ceiling value of $36,690. The contract contains no set-aside designation and is scheduled for ultimate completion by September 30, 2025, with performance taking place in Miami, FL. These specialized medical devices are radiopharmaceutical products used in selective internal...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 22, awarded a $487,056 firm fixed-price delivery order to Sirtex Medical Inc. for Y-90 SIR-Spheres resin microspheres at the company's Woburn, Massachusetts facility. The contract, effective January 1, 2026, extends through December 31, 2026, and represents a continuation of the VA's procurement of specialized radiopharmaceutical devices used in selective internal radiation therapy (SIRT) to treat liver tumors and...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sirtex Medical Inc., a global healthcare company that provides medical devices and therapies for cancer treatment. The contract is for the purchase of Y-90 SIR-Spheres, which are resin microspheres used in selective internal radiation therapy to treat inoperable liver tumors and metastatic disease in veterans and military members. The potential value of the contract is $142,000.00, and it has a...
- The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Sirtex Medical Inc., a global healthcare company, to provide radiopharmaceutical products. The contract, valued at $115,727.00, is for the supply of Sirtex's Sir-Spheres Y-90 resin microspheres, which are used in selective internal radiation therapy to treat liver tumors and metastatic disease for veterans. The contract does not have a set-aside designation and is for...
- The Department of Veterans Affairs Veterans Health Administration awarded a $148,500 firm-fixed-price purchase order to Sirtex Medical Inc. on September 7, 2018 to provide Sir-Spheres Y-90 resin microspheres for use in selective internal radiation therapy at VA medical centers. This award had no set-aside designation. Sirtex Medical, a global healthcare company, is the prime contractor providing these specialized radioactive microspheres that are used to treat inoperable liver cancer in...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a global healthcare company, for the provision of SIR-Spheres Y-90 resin microspheres and related medical devices. The contract, valued at $18,345.00, has an ultimate completion date of January 10, 2025. The SIR-Spheres are a targeted radiation therapy used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a $869,436 firm fixed-price definitive contract to Sirtex Medical Inc. on May 25, 2022, for the supply of SIR-Spheres Y-90 resin microspheres to the VA Southern Arizona Healthcare System in Tucson, Arizona. This specialized medical device is used in selective internal radiation therapy (SIRT) procedures to treat veterans with primary and metastatic liver disease. The contract extends through December 31, 2025,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA VISN 8) awarded a $17,995 purchase order to Sirtex Medical Inc. of Woburn, Massachusetts for a dose of Y-90 SIRSpheres. SIRSpheres are medical devices used for selective internal radiation therapy to treat inoperable liver cancer and metastases. Under this firm fixed price contract running from October 18, 2023 to November 7, 2023, Sirtex Medical will deliver the prescribed dose of...
- This is a $17,750 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a for-profit medical device manufacturer. The contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The award has a performance period through February 22, 2023, and is not designated as a set-aside contract. Sirtex Medical Inc. is a global healthcare...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm fixed-price purchase order contract to Sirtex Medical Inc. for the provision of chemotherapy treatment services. The contract, valued at $17,995.00, supports the delivery of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy used to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver. This contract, which does not have a set-aside designation, will deliver these...
The Department of Veterans Affairs, through Veterans Integrated Service Network 21, awarded a $1,800 firm fixed-price purchase order to Sirtex Medical Inc. on October 1, 2023, for Y-90 resin SIR-Spheres microspheres. This specialized medical device is used in selective internal radiation therapy (SIRT) procedures to treat liver tumors and metastatic colorectal cancer in veteran patients. The contract, which was not designated as a set-aside, has a completion date of September 30, 2024, and will be performed at Sirtex Medical's facility in Woburn, Massachusetts. The award originated from a pre-solicitation posted on May 22, 2023, with a due date of May 25, 2023. Sirtex Medical Inc., a global healthcare company specializing in innovative cancer therapies and targeted radiation treatment technologies, has established itself as a critical supplier to the VA and Department of Defense. The company holds significant blanket purchase agreements with both the VA's Veterans Integrated Service Network 19 (valued at $708,270 through July 2028) and the Defense Health Agency (valued at $1.1 million through June 2030), enabling streamlined procurement of advanced radiopharmaceutical products across multiple federal healthcare facilities. This purchase order represents a routine acquisition under the broader VA procurement framework to support cancer treatment capabilities for the veteran population.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Y-90 resin SIR microspheres Brand Name or Equal | 36C26123Q0746 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Pre-Solicitation 1/1 | 5/22/23, 3:16 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($165k) | 9/4/25 | |
| Not listed | Not listed | $166.4k | 10/1/23 |